Hims & Hers Stock Trades $37.98-$40 on Obesity, GLP/GIP Biotech Interest with Recent Bounce

Shares of Hims & Hers Health Inc. ($HIMS) have attracted renewed investor interest in the obesity and GLP/GIP biotech sectors. Market participants have been actively trading the stock around the $38 to $40 price range, with some adding to positions on dips and others trimming holdings near $37.98. The stock has experienced a bounce recently, prompting some investors to maintain or adjust their exposure within this price band.